meta_pixel
Tapesearch Logo
Log in
Science Friday

Herd Immunity, Crossword Program. May 7, 2021, Part 1

Science Friday

Science Friday and WNYC Studios

Science, Life Sciences, Wnyc, Natural Sciences, Friday

4.4 • 6.3K Ratings

🗓️ 7 May 2021

⏱️ 47 minutes

🧾️ Download transcript

Summary

Weighing COVID-19 Vaccinations For Teens Federal officials are reporting that the Food and Drug Administration is poised to authorize Pfizer’s COVID-19 vaccine for children ages 12 to 15 by early next week—just as Canada became the first country to do so on Wednesday of this week. Pfizer has said they will seek out emergency authorization for even younger kids by the fall. But as most countries still lag far behind the United States in vaccine access for adults, public health officials are questioning the ethics of prioritizing American teens over adults from other countries. Science writer Maggie Koerth joins Ira with more on the accessibility of COVID-19 vaccines for children, new projections of rapid sea level rise under climate change, and other stories from the week. Is COVID-19 Herd Immunity Even Possible Anymore? Since the start of the pandemic, we’ve equated getting out of this mess with the concept of herd immunity—when a certain percentage of the population is immune to a disease, mostly through vaccination. With COVID-19, experts have said we need somewhere around 70 to 90% of the population to be immunized to meet this goal. Now that all adults in the U.S. are eligible for the vaccine, how far are we from that goal? And what is our trajectory? Some experts now say with variants and vaccine hesitancy, herd immunity may not be possible here in the U.S. Joining Ira to break down this and other coronavirus quandaries is Angela Rasmussen, research scientist at VIDO-InterVac, the University of Saskatchewan’s vaccine research institute in Saskatoon, Saskatchewan. This Computer Won The 2021 American Crossword Puzzle Tournament In 2012, a computer program named Dr. Fill placed 141st out of some 660 entries in that year’s American Crossword Puzzle Tournament, a competition for elite crossword puzzle solvers. This year, the algorithm beat the human competition, completing the final playoff puzzle in just 49 seconds.  The A.I. relies on a collection of different techniques to make sense of a puzzle. Sometimes, a simple fact is needed—who was the First Lady before Eleanor Roosevelt? (Lou Henry Hoover.) More often, however, crossword puzzle solutions rely not just on factual knowledge, but an ability to recognize themes that puzzle constructors have embedded in the crosswords, along with an understanding of puns, homonyms, and word play. (Think: Five letters, “dining table leaves”—SALAD!) The program makes a series of statistical calculations about likely answers, then tries to fit those possibilities into the puzzle squares.  This year, researchers from the Berkeley Natural Language Processing group added their expertise to Dr. Fill’s algorithms—a contribution that may have helped push Dr. Fill to its crowning victory.  But the program isn’t infallible. This year, it made three mistakes solving puzzles during the tournament, while some human solvers completed the puzzles perfectly. It can make these errors with any unique puzzle form it’s never seen before.  Matt Ginsberg, the computer programmer behind Dr. Fill, joins Ira to talk about the competition and the advances his program has made over the years.

Transcript

Click on a timestamp to play from that location

0:00.0

This is Science Friday. I'm Ira Flato. A bit later in the hour answering evolving COVID-19 questions,

0:06.9

and a crossword puzzle-solving computer program that beats human competitors. But first, even as the U.S.

0:14.5

approaches a third of adults fully vaccinated, COVID-19 cases continue to rise in other countries. We've talked about India, where health care systems are verging on COVID-19 cases continue to rise in other countries. We've talked about India, where health

0:23.4

care systems are verging on collapse. But cases are also rising in Nepal, Thailand, Cambodia,

0:29.8

and elsewhere. To address the disparity of vaccine access between rich and poor nations,

0:35.1

the Biden administration announced this week it would support

0:38.9

waiving intellectual property rights for COVID-19 vaccines. This would allow countries to

0:45.6

manufacture their own. Some like the U.S., Great Britain, and the European Union have objected

0:52.0

in the past to waiving patent rights, so negotiations remain ahead for the

0:57.5

World Trade Organization. Later in the hour in our conversation with virologist Angela Rasmussen,

1:03.3

we will talk more about why waiving the patent restrictions alone may not be enough.

1:09.7

But first, Pfizer announced today it will seek full authorization

1:13.3

from the FDA for their COVID-19 vaccine. And earlier this week, Pfizer announced that it

1:20.0

would also seek emergency authorization for use of their vaccine in children, 12 to 15 years old.

1:30.4

Here to tell us more about that, plus other stories from the week is 538 senior science reporter Maggie Kerth. She joins us from Minneapolis.

1:36.3

Hey, welcome back, Maggie. Hi, thanks for having me here. You're welcome. You know, many parents and

1:42.6

grandparents of adolescents find this news very exciting.

1:46.5

They would love to see that age range for Pfizer vaccine expanded, right?

1:50.8

Yes, very much. I am a parent of a seven-and-five-year-old, and I am very exciting because it means

1:56.2

we're getting a little bit closer to my kids getting something.

2:00.2

So that means we should expect, then, if this is successful for this age group that, of course,

2:05.5

right down the line, we might go even younger.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Science Friday and WNYC Studios, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Science Friday and WNYC Studios and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.